Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study

Maas, 2017, Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research, Lancet Neurol, 16, 987, 10.1016/S1474-4422(17)30371-X Buki, 2015, Minor and repetitive head injury, Adv Tech Stand Neurosurg, 42, 147, 10.1007/978-3-319-09066-5_8 Dijkland, 2020, Prognosis in moderate and severe traumatic brain injury: a systematic review of contemporary models and validation studies, J Neurotrauma, 37, 1, 10.1089/neu.2019.6401 Steyerberg, 2008, Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics, PLoS Med, 5, e165, 10.1371/journal.pmed.0050165 Perel, 2008, Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients, BMJ, 336, 425, 10.1136/bmj.39461.643438.25 Mikolić, 2021, Prediction of global functional outcome and post-concussive symptoms after mild traumatic brain injury: external validation of prognostic models in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, J Neurotrauma, 38, 196 Kim, 2020, Defining the surgical critical care research agenda: results of a gaps analysis from the Critical Care Committee of the American Association for the Surgery of Trauma, J Trauma Acute Care Surg, 88, 320, 10.1097/TA.0000000000002532 Mondello, 2021, Blood-based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild brain injury: a living systematic review and meta-analysis, J Neurotrauma, 38, 1086, 10.1089/neu.2017.5182 Undén, 2013, Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update, BMC Medicine, 11, 1, 10.1186/1741-7015-11-50 Bazarian, 2018, Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study, Lancet Neurol, 17, 782, 10.1016/S1474-4422(18)30231-X Vos, 2010, GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study, Neurology, 75, 1786, 10.1212/WNL.0b013e3181fd62d2 Zhang, 2014, Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury, Peptides, 60, 13, 10.1016/j.peptides.2014.07.016 Di Battista, 2015, Blood biomarkers in moderate-to-severe traumatic brain injury: potential utility of a multi-marker approach in characterizing outcome, Front Neurol, 6, 110, 10.3389/fneur.2015.00110 Gradisek, 2021, Prognostic value of a combination of circulating biomarkers in critically ill patients with traumatic brain injury: results from the European CREACTIVE study, J Neurotrauma, 38, 2667, 10.1089/neu.2021.0066 Graham, 2021, Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury, Sci Transl Med, 13, 10.1126/scitranslmed.abg9922 Mondello, 2011, Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study, Crit Care, 15, R156, 10.1186/cc10286 Takala, 2016, Glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 as outcome predictors in traumatic brain injury, World Neurosurg, 87, 8, 10.1016/j.wneu.2015.10.066 Huie, 2021, Biomarkers for traumatic brain injury: data standards and statistical considerations, J Neurotrauma, 38, 2514, 10.1089/neu.2019.6762 Steyerberg, 2019, Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study, Lancet Neurol, 18, 923, 10.1016/S1474-4422(19)30232-7 Maas, 2015, Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study, Neurosurgery, 76, 67, 10.1227/NEU.0000000000000575 van Buuren, 2018 Czeiter, 2020, Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study, EBioMedicine, 56, 10.1016/j.ebiom.2020.102785 Wilson, 2021, A manual for the Glasgow Outcome Scale-Extended interview, J Neurotrauma, 38, 2435, 10.1089/neu.2020.7527 Kunzmann, 2021, Imputation of ordinal outcomes: a comparison of approaches in traumatic brain injury, J Neurotrauma, 38, 455, 10.1089/neu.2019.6858 Steyerberg, 2008 Takala, 2016, Glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 as outcome predictors in traumatic brain injury, World Neurosurg, 87, 8, 10.1016/j.wneu.2015.10.066 Papa, 2010, Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury, Crit Care Med, 38, 138, 10.1097/CCM.0b013e3181b788ab Haimoto, 1987, Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues, Lab Invest, 57, 489 Okonkwo, 2020, Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study, J Neurotrauma, 37, 2460, 10.1089/neu.2020.7140 Yue, 2019, Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study, Lancet Neurol, 18, 953, 10.1016/S1474-4422(19)30282-0 Whitehouse, 2022, Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: a CENTER-TBI study, EBioMedicine, 75, 10.1016/j.ebiom.2021.103777 Mondello, 2012, Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury, J Neurotrauma, 29, 1096, 10.1089/neu.2011.2092 Thelin, 2019, A serum protein biomarker panel improves outcome prediction in human traumatic brain injury, J Neurotrauma, 36, 2850, 10.1089/neu.2019.6375 Mikolić, 2021, Differences between men and women in treatment and outcome after traumatic brain injury, J Neurotrauma, 38, 235, 10.1089/neu.2021.0116 Mikolić, 2021, Explaining outcome differences between men and women following mild traumatic brain injury, J Neurotrauma, 38, 3315, 10.1089/neu.2021.0116 Thelin, 2017, Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review, Front Neurol, 8, 300, 10.3389/fneur.2017.00300